Genistein as antiviral drug against HIV ion channel

Planta Medica

Volumn 80, Issue 8-9, 2014, Pages 682-687

  Sauter, Daniel ^a,b,d   Schwarz, Silvia ^a   Wang, Kai ^c   Zhang, Ronghua ^c   Sun, Bing ^c   Schwarz, Wolfgang ^a,b  

^a Shanghai Research Center for Acupuncture and Meridians   (China)

^b GOETHE UNIVERSITY   (Germany)

^c INSTITUTE PASTEUR OF SHANGHAI   (China)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

flavonoids; genistein; HIV 1; ion channel; virus release

Indexed keywords

ANTIVIRUS AGENT; GENISTEIN; ION CHANNEL; NARINGENIN; VPU PROTEIN; COMPLEMENTARY RNA; FLAVANONE DERIVATIVE; FLAVONOID; HUMAN IMMUNODEFICIENCY VIRUS PROTEIN; VIRUS PROTEIN; VPU PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DEGRADATION; DEPOLARIZATION; FEMALE; HUMAN IMMUNODEFICIENCY VIRUS; LIPID BILAYER; MEMBRANE CURRENT; NONHUMAN; OOCYTE; PROTEIN TARGETING; QUANTITATIVE ANALYSIS; WESTERN BLOTTING; XENOPUS; ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMISTRY; DRUG EFFECTS; GENE EXPRESSION; GENETICS; HIV INFECTIONS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; PATCH CLAMP TECHNIQUE; TRANSGENE; VIRUS RELEASE; XENOPUS LAEVIS;

ANIMALS; ANTIVIRAL AGENTS; FEMALE; FLAVANONES; FLAVONOIDS; GENE EXPRESSION; GENISTEIN; HIV INFECTIONS; HIV-1; HUMAN IMMUNODEFICIENCY VIRUS PROTEINS; HUMANS; ION CHANNELS; PATCH-CLAMP TECHNIQUES; RNA, COMPLEMENTARY; TRANSGENES; VIRAL REGULATORY AND ACCESSORY PROTEINS; VIRUS RELEASE; XENOPUS LAEVIS;

EID: 84903287183     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0034-1368583     Document Type: Article

References (35)

1. Fischer W. B., Thiel G., Fink R. HA. Viral membrane proteins. Eur Biophys J: 2010; 39 1041 1042
2. Krüger J., Fischer W. B. Assembly of viral membrane proteins. J Chem Theory Comput: 2009; 5 2503 2513
3. Wang K., Xie S., Sun B. Viral proteins function as ion channels. Biochim Biophys Acta: 2011; 1808 510 515
4. Fischer W. B., Krüger J. Viral channel-forming proteins. Int Rev Cell Mol Biol: 2009; 275 35 63
5. Liang X., Li Z. Y. Ion channels as antivirus targets. Virol Sin: 2010; 25 267 280
6. Kelly M. L., Cook J. A., Brown-Augsburger P., Heinz B. A., Smith M. C., Pinto L. H. Demonstrating the intrinsic ion channel activity of virally encoded proteins. FEBS Lett: 2003; 552 61 67
7. Montal M. Structure-function correlates of Vpu, a membrane protein of HIV-1. FEBS Lett: 2003; 552 47 53
8. Lu W., Zheng B. J., Xu K., Schwarz W., Du L. Y., Wong C. KL, Chen J. D., Duan S. M., Deubel V., Sun B. Severe acute respiratory syndrome-associated coronavirus 3a protein forms an ion channel and modulates virus release. Proc Natl Acad Sci U S A: 2006; 103 12540 12545
9. Hsu K., Han J., Shinlapawittayatom K., Deschenes I., Marban E. Membrane potential depolarization as a triggering mechanism for Vpu-mediated HIV-1 release. Biophys J: 2010; 99 1718 1725
10. Bour S., Strebel K. The HIV-1 Vpu protein: a multifunctional enhancer of viral particle release. Microbes Infect: 2003; 5 1029 1039
11. McNatt M. W., Zang T., Bieniasz P. D. Vpu binds directly to tetherin and displaces it from nascent virions. PLoS Pathog: 2013; 9 e1003299
12. Neil S. JD, Zang T., Bieniasz P. D. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature: 2008; 451 425 430
13. Strebel K. HIV-1 Vpu: an ion channel in search of a job. Biochim Biophys Acta: 2014; 1838 1074 1081
14. Schubert U., Ferrer-Montiel A. V., Oblatt-Montal M., Henklein P., Strebel K., Montal M. Identification of an ion channel activity of the Vpu transmembrane domain and its involvement in the regulation of virus release from HIV-1-infected cells. FEBS Lett: 1996; 398 12 18
15. Van Damme N., Goff D., Katsura C., Jorgenson R. L., Mitchell R., Johnson M. C., Stephens E. B., Guatelli J. The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein. Cell Host Microbe: 2008; 3 245 252
16. Strebel K. HIV-1 Vpu: putting a channel to the TASK. Mol Cell: 2004; 14 150 152
17. Hussain A., Das S., Tanwar C., Jameel S. Oligomerization of the human immunodeficiency virus type 1 (HIV-1) Vpu protein - a genetic, biochemical and biophysical analysis. Virol J: 2007; 4 81
18. Ewart G. D., Sutherland T., Gage P. W., Cox G. B. The Vpu protein of human immunodeficiency virus type 1 forms cation-selective ion channels. J Virol: 1996; 70 7108 7115
19. Schwarz S., Sauter D., Lu W., Wang K., Sun B., Efferth T., Schwarz W. Coronaviral ion channels as target for Chinese herbal medicine. Forum Immunopathol Dis Therap: 2012; 3 1 13
20. Tan W., Lu J., Huang M., Li Y., Chen M., Wu G., Gong J., Zhong Z., Xu Z., Dang Y., Guo J., Chen X., Wang Y. Anti-cancer natural products isolated from Chinese medicinal herbs. Chin Med: 2011; 6 27-15
21. Lown J. W. Anthracycline and anthraquinone anticancer agents: Current status and recent developments. Pharmacol Ther: 1993; 60 185 214
22. Naithani R., Huma L. C., Holland L. E., Shukla D., McCormick D. L., Mehta R. G., Moriarty R. M. Antiviral activity of phytochemicals: A comprehensive review. Mini Rev Med Chem: 2008; 8 1106 1133
23. Mehnert T., Routh A., Judge P. J., Lam Y. H., Fischer D., Watts A., Fischer W. B. Biophysical characterization of Vpu from HIV-1 suggests a channel-pore dualism. Proteins: 2008; 70 1488 1497
24. Lyu S. Y., Rhim J. Y., Park W. B. Antiherpetic activities of flavonoids against herpes simplex virus type 1 (HSV-1) and type 2 (SV-2) in vitro. Arch Pharm Res: 2005; 28 1293 1301
25. Mitrocotsa D., Mitaku S., Axarlis S., Harvala C., Malamas M. Evaluation of the antiviral activity of kaempferol and its glycosides against human cytomegalovirus. Planta Med: 2000; 66 377 379
26. Zielonka J., Gebicki J., Grynkiewicz G. Radical scavenging properties of genistein. Free Radic Biol Med: 2003; 35 958 965
27. Andres A., Donovan S. M., Kuhlenschmidt M. S. Soy isoflavones and virus infections. J Nutr Biochem: 2009; 20 563 569
28. Stantchev T. S., Markovic I., Telford W. G., Clouse K. A., Broder C. C. The tyrosine kinase inhibitor genistein blocks HIV-1 infection in primary human macrophages. Virus Res: 2007; 123 178 189
29. Schwarz S., Wang K., Yu W., Sun B., Schwarz W. Emodin inhibits current through SARS-associated coronavirus 3a protein. Antiviral Res: 2011; 90 64 69
30. Schwarz S., Sauter D., Wang K., Zhang R. H., Sun B., Karioti A., Bilia A. R., Efferth T., Schwarz W. Kaempferol derivatives as antiviral drugs against 3a channel protein of coronavirus. Planta Med: 2014; 80 177 182
31. Lu W., Xu K., Sun B. SARS accessory proteins ORF3a and 9b and their functional analysis. In: Lal S. K. editor Molecular biology of the SARS-coronavirus. Berlin, Heidelberg Springer: 2010; 167 175
32. Zhou Y., Frey T. K., Yang J. J. Viral calciomics: Interplays between Ca2+ and virus. Cell Calcium: 2009; 46 1 17
33. Kuhl B. D., Cheng V., Donahue D. A., Sloan R. D., Liang C., Wilkinson J., Wainberg M. A. The HIV-1 Vpu viroporin inhibitor BIT225 does not affect Vpu-mediated tetherin antagonism. PLoS One: 2011; 6 e27660
34. Dumont J. N. Oogenesis in Xenopus laevis (Daudin): I. Stages of oocyte development in laboratory maintained animals. J Morphol: 1972; 136 153 180
35. Herrero L., Monroy N., González M. E. HIV-1 Vpu protein mediates the transport of potassium in Saccharomyces cerevisiae. Biochemistry: 2013; 52 171 177